Off the wire
• China's Red Flag Canal eyes World Heritage status  • Japanese professor urges gov't to face history to move forward  • News Analysis: PM's resignation shift mirrors Libya's political chaos  • Feature: Kenyan coffee shops spruce up for bonanza in cold season  • Feature: Survivors of bomb attacks wonder why civilians are being targeted  • 1st LD Writethru: Pearson to sell stake in Economist Group, to focus on education  • China Focus: Chinese exporters see limited impact from weakening yuan  • German gov't sees economy in solid upswing  • Industry insiders: China to become world's largest market for new energy vehicles  • China urges reform of government-linked trade associations  
You are here: 　 Home

U.S. FDA recalls TV star's Instagram post on drug promotion

Xinhua, August 12, 2015 Adjust font size:

After reality TV star Kim Kardashian instagrammed her enthusiasm about a morning sickness drug, the U.S. Food and Drug Administration (FDA) has ordered her to remove the post as she failed to mention any related risks.

The FDA released a warning letter Tuesday, saying Kardashian's social media post on Diclegis, a drug she credited for helping with morning sickness, violates federal drug promotion rules.

Kardashian, 34, has more than 42.5 million Instagram followers and 34 million Twitter followers.

A portion of the celebrity's original Instagram post read: "(My doctor) prescribed me Diclegis, I felt a lot better and most importantly, it's been studied and there was no increased risk to the baby. I'm so excited and happy with my results that I'm partnering with Duchesnay USA to raise awareness about treating morning sickness."

The Office of Prescription Drug Promotion of the FDA has reviewed Kardashian's social media post, said the warning letter.

"The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information associated with its use and it omits material facts," it said.

The warning letter, dated Aug. 7, noted that the label of the drug, which describes its approved uses, includes important limitations on the use of the drug which Kardashian failed to mention online.

The drug hasn't been studied in women with a rare complication of pregnancy that causes extreme morning sickness, the letter said.

It added that Diclegis has actually not recommended at all for women sensitive to various drugs, saying the drug label comes with warnings and precautions for activities requiring mental alertness.

The social media post of Kardashian's cheek next to a bottle of Diclegis, made by Duchesnay USA, has since been deleted from her account. Endi